Current scenario for the hepatoprotective effects of Inchinkoto, a traditional herbal medicine, and its clinical application in liver surgery: A review

Hepatology Research

Volumn 44, Issue 4, 2014, Pages 384-394

  Yokoyama, Yukihiro ^a   Nagino, Masato ^a  

^a NAGOYA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

Anti inflammatory; Antioxidative; Hepatectomy; Hepatoprotective; Herbal medicine

Indexed keywords

GENIPIN; GENIPOSIDE; HERBACEOUS AGENT; INCHINKOTO; LIVER PROTECTIVE AGENT; TRANSFORMING GROWTH FACTOR BETA1; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ARTICLE; HERBAL MEDICINE; HUMAN; LIVER CELL; LIVER PROTECTION; LIVER SURGERY; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; TRADITIONAL MEDICINE; UPREGULATION;

EID: 84898601902     PISSN: 13866346     EISSN: 1872034X     Source Type: Journal    
DOI: 10.1111/hepr.12299     Document Type: Article

References (74)

1. Kono T, Kaneko A, Omiya Y, Ohbuchi K, Ohno N, Yamamoto M. Epithelial transient receptor potential ankyrin 1 (TRPA1)-dependent adrenomedullin upregulates blood flow in rat small intestine. Am J Physiol Gastrointest Liver Physiol 2013; 304: G428-436.
2. Takeda H, Sadakane C, Hattori T etal. Rikkunshito, an herbal medicine, suppresses cisplatin-induced anorexia in rats via 5-HT2 receptor antagonism. Gastroenterology 2008; 134: 2004-2013.
3. Shoda J, Miura T, Utsunomiya H etal. Genipin enhances Mrp2 (Abcc2)-mediated bile formation and organic anion transport in rat liver. Hepatology 2004; 39 (1): 167-178.
4. Wang L, Zhang RM, Liu GY etal. Chinese herbs in treatment of influenza: a randomized, double-blind, placebo-controlled trial. Respir Med 2010; 104: 1362-1369.
5. Satoh N, Sakai S, Kogure T etal. A randomized double blind placebo-controlled clinical trial of Hochuekkito, a traditional herbal medicine, in the treatment of elderly patients with weakness N of one and responder restricted design. Phytomedicine 2005; 12: 549-554.
6. Iwasaki K, Satoh-Nakagawa T, Maruyama M etal. A randomized, observer-blind, controlled trial of the traditional Chinese medicine Yi-Gan San for improvement of behavioral and psychological symptoms and activities of daily living in dementia patients. J Clin Psychiatry 2005; 66: 248-252.
7. Urata Y, Yoshida S, Irie Y etal. Treatment of asthma patients with herbal medicine TJ-96: a randomized controlled trial. Respir Med 2002; 96: 469-474.
8. Yamamoto M, Miura N, Ohtake N etal. Genipin, a metabolite derived from the herbal medicine Inchin-ko-to, and suppression of Fas-induced lethal liver apoptosis in mice. Gastroenterology 2000; 118: 380-389.
9. Yamamoto M, Ogawa K, Morita M, Fukuda K, Komatsu Y. The herbal medicine Inchin-ko-to inhibits liver cell apoptosis induced by transforming growth factor beta 1. Hepatology 1996; 23: 552-559.
10. Okada K, Shoda J, Kano M etal. Inchinkoto, a herbal medicine, and its ingredients dually exert Mrp2/MRP2-mediated choleresis and Nrf2-mediated antioxidative action in rat livers. Am J Physiol Gastrointest Liver Physiol 2007; 292: G1450-1463.
11. Leu JI, Crissey MA, Taub R. Massive hepatic apoptosis associated with TGF-beta1 activation after Fas ligand treatment of IGF binding protein-1-deficient mice. J Clin Invest 2003; 111 (1): 129-139.
12. Kobayashi H, Horikoshi K, Yamataka A, Lane GJ, Yamamoto M, Miyano T. Beneficial effect of a traditional herbal medicine (inchin-ko-to) in postoperative biliary atresia patients. Pediatr Surg Int 2001; 17: 386-389.
13. Watanabe S, Yokoyama Y, Oda K etal. Choleretic effect of inchinkoto, a herbal medicine, on livers of patients with biliary obstruction due to bile duct carcinoma. Hepatol Res 2009; 39: 247-255.
14. Kaiho T, Tsuchiya S, Yanagisawa S etal. Effect of the herbal medicine Inchin-Ko-To for serum bilirubin in hepatectomized patients. Hepatogastroenterology 2008; 55 (81): 150-154.
15. Huang W, Zhang J, Moore DD. A traditional herbal medicine enhances bilirubin clearance by activating the nuclear receptor CAR. J Clin Invest 2004; 113 (1): 137-143.
16. Takeuchi S, Goto T, Mikami K etal. Genipin prevents fulminant hepatic failure resulting in reduction of lethality through the suppression of TNF-alpha production. Hepatol Res 2005; 33: 298-305.
17. Yamashiki M, Mase A, Arai I etal. Effects of the Japanese herbal medicine "Inchinko-to" (TJ-135) on concanavalin A-induced hepatitis in mice. Clin Sci (Lond) 2000; 99: 421-431.
18. Kawai K, Yokoyama Y, Kokuryo T, Watanabe K, Kitagawa T, Nagino M. Inchinkoto, an herbal medicine, exerts beneficial effects in the rat liver under stress with hepatic ischemia-reperfusion and subsequent hepatectomy. Ann Surg 2010; 251: 692-700.
19. Matsuura T, Kaibori M, Araki Y etal. Japanese herbal medicine, inchinkoto, inhibits inducible nitric oxide synthase induction in interleukin-1beta-stimulated hepatocytes. Hepatol Res 2012; 42 (1): 76-90.
20. Koo HJ, Song YS, Kim HJ etal. Antiinflammatory effects of genipin, an active principle of gardenia. Eur J Pharmacol 2004; 495: 201-208.
21. Imanishi Y, Maeda N, Otogawa K etal. Herb medicine Inchin-ko-to (TJ-135) regulates PDGF-BB-dependent signaling pathways of hepatic stellate cells in primary culture and attenuates development of liver fibrosis induced by thioacetamide administration in rats. J Hepatol 2004; 41: 242-250.
22. Sakaida I, Tsuchiya M, Kawaguchi K, Kimura T, Terai S, Herbal OK. medicine Inchin-ko-to (TJ-135) prevents liver fibrosis and enzyme-altered lesions in rat liver cirrhosis induced by a choline-deficient L-amino acid-defined diet. J Hepatol 2003; 38: 762-769.
23. Ikeda H, Nagashima K, Yanase M etal. The herbal medicine inchin-ko-to (TJ-135) induces apoptosis in cultured rat hepatic stellate cells. Life Sci 2006; 78: 2226-2233.
24. Chu CY, Tseng TH, Hwang JM, Chou FP, Wang CJ. Protective effects of capillarisin on tert-butylhydroperoxide-induced oxidative damage in rat primary hepatocytes. Arch Toxicol 1999; 73: 263-268.
25. Trauner M, Meier PJ, Boyer JL. Molecular pathogenesis of cholestasis. N Engl J Med 1998; 339: 1217-1227.
26. Geier A, Dietrich CG, Lammert F etal. Regulation of organic anion transporters in a new rat model of acute and chronic cholangitis resembling human primary sclerosing cholangitis. J Hepatol 2002; 36: 718-724.
27. Kullak-Ublick GA, Baretton GB, Oswald M, Renner EL, Paumgartner G, Beuers U. Expression of the hepatocyte canalicular multidrug resistance protein (MRP2) in primary biliary cirrhosis. Hepatol Res 2002; 23 (1): 78-82.
28. Trauner M, Arrese M, Soroka CJ etal. The rat canalicular conjugate export pump (Mrp2) is down-regulated in intrahepatic and obstructive cholestasis. Gastroenterology 1997; 113 (1): 255-264.
29. Yamada T, Arai T, Nagino M etal. Impaired expression of hepatic multidrug resistance protein 2 is associated with posthepatectomy hyperbilirubinemia in patients with biliary cancer. Langenbecks Arch Surg 2005; 390: 421-429.
30. Bolder U, Ton-Nu HT, Schteingart CD, Frick E, Hofmann AF. Hepatocyte transport of bile acids and organic anions in endotoxemic rats: impaired uptake and secretion. Gastroenterology 1997; 112 (1): 214-225.
31. Bossard R, Stieger B, O'Neill B, Fricker G, Meier PJ. Ethinylestradiol treatment induces multiple canalicular membrane transport alterations in rat liver. J Clin Invest 1993; 91: 2714-2720.
32. Kanzler S, Galle PR. Apoptosis and the liver. Semin Cancer Biol 2000; 10: 173-184.
33. Brouckaert P, Fiers W. Tumor necrosis factor and the systemic inflammatory response syndrome. Curr Top Microbiol Immunol 1996; 216: 167-187.
34. Osawa Y, Nagaki M, Banno Y etal. Possible involvement of reactive oxygen species in d-galactosamine-induced sensitization against tumor necrosis factor-alpha-induced hepatocyte apoptosis. J Cell Physiol 2001; 187: 374-385.
35. Arab JP, Ramirez C, Munoz P etal. Effects of Japanese herbal medicine Inchin-ko-to on endotoxin-induced cholestasis in the rat. Ann Hepatol 2009; 8: 228-233.
36. Szabo C, Billiar TR. Novel roles of nitric oxide in hemorrhagic shock. Shock 1999; 12 (1): 1-9.
37. Lee VG, Johnson ML, Baust J, Laubach VE, Watkins SC, Billiar TR. The roles of iNOS in liver ischemia-reperfusion injury. Shock 2001; 16: 355-360.
38. Carnovale CE, Scapini C, Alvarez ML, Favre C, Monti J, Carrillo MC. Nitric oxide release and enhancement of lipid peroxidation in regenerating rat liver. J Hepatol 2000; 32: 798-804.
39. Watanabe N, Miura S, Zeki S, Ishii H. Hepatocellular oxidative DNA injury induced by macrophage-derived nitric oxide. Free Radic Biol Med 2001; 30: 1019-1028.
40. Mizumoto M, Arii S, Furutani M etal. NO as an indicator of portal hemodynamics and the role of iNOS in increased NO production in CCl4-induced liver cirrhosis. J Surg Res 1997; 70: 124-133.
41. Lee KS, Buck M, Houglum K, Chojkier M. Activation of hepatic stellate cells by TGF alpha and collagen type I is mediated by oxidative stress through c-myb expression. J Clin Invest 1995; 96: 2461-2468.
42. Pinzani M, Milani S, De Franco R etal. Endothelin 1 is overexpressed in human cirrhotic liver and exerts multiple effects on activated hepatic stellate cells. Gastroenterology 1996; 110: 534-548.
43. Garcia-Trevijano ER, Iraburu MJ, Fontana L etal. Transforming growth factor beta1 induces the expression of alpha1(I) procollagen mRNA by a hydrogen peroxide-C/EBPbeta-dependent mechanism in rat hepatic stellate cells. Hepatology 1999; 29: 960-970.
44. Davis BH, Rapp UR, Davidson NO. Retinoic acid and transforming growth factor beta differentially inhibit platelet-derived-growth-factor-induced Ito-cell activation. Biochem J 1991; 278 (Pt 1): 43-47.
45. Friedman SL, Arthur MJ. Activation of cultured rat hepatic lipocytes by Kupffer cell conditioned medium. Direct enhancement of matrix synthesis and stimulation of cell proliferation via induction of platelet-derived growth factor receptors. J Clin Invest 1989; 84: 1780-1785.
46. Gressner AM. Cytokines and cellular crosstalk involved in the activation of fat-storing cells. J Hepatol 1995; 22 (2 Suppl): 28-36.
47. Ikeda K, Wakahara T, Wang YQ, Kadoya H, Kawada N, Kaneda K. In vitro migratory potential of rat quiescent hepatic stellate cells and its augmentation by cell activation. Hepatology 1999; 29: 1760-1767.
48. Inao M, Mochida S, Matsui A etal. Japanese herbal medicine Inchin-ko-to as a therapeutic drug for liver fibrosis. J Hepatol 2004; 41: 584-591.
49. Taylor DE, Ghio AJ, Piantadosi CA. Reactive oxygen species produced by liver mitochondria of rats in sepsis. Arch Biochem Biophys 1995; 316 (1): 70-76.
50. Spolarics Z. Endotoxin stimulates gene expression of ROS-eliminating pathways in rat hepatic endothelial and Kupffer cells. Am J Physiol 1996; 270 (4 Pt 1): G660-666.
51. Bilzer M, Paumgartner G, Gerbes AL. Glutathione protects the rat liver against reperfusion injury after hypothermic preservation. Gastroenterology 1999; 117 (1): 200-210.
52. Liu TZ, Lee KT, Chern CL, Cheng JT, Stern A, Tsai LY. Free radical-triggered hepatic injury of experimental obstructive jaundice of rats involves overproduction of proinflammatory cytokines and enhanced activation of nuclear factor kappaB. Ann Clin Lab Sci 2001; 31: 383-390.
53. Kalish GH, Di Luzio NR. Peroxidation of liver lipids in the pathogenesis of the ethanol-induced fatty liver. Science 1966; 152 (3727): 1390-1392.
54. Ji B, Ito K, Sekine S, Tajima A, Horie T. Ethacrynic-acid-induced glutathione depletion and oxidative stress in normal and Mrp2-deficient rat liver. Free Radic Biol Med 2004; 37: 1718-1729.
55. Kanz MF, Dugas TR, Liu H, Santa Cruz V. Glutathione depletion exacerbates methylenedianiline toxicity to biliary epithelial cells and hepatocytes in rats. Toxicol Sci 2003; 74: 447-456.
56. Stocker R, Yamamoto Y, McDonagh AF, Glazer AN, Ames BN. Bilirubin is an antioxidant of possible physiological importance. Science 1987; 235 (4792): 1043-1046.
57. Kikuchi G, Yoshida T, Noguchi M. Heme oxygenase and heme degradation. Biochem Biophys Res Commun 2005; 338 (1): 558-567.
58. Ishii T, Itoh K, Takahashi S etal. Transcription factor Nrf2 coordinately regulates a group of oxidative stress-inducible genes in macrophages. J Biol Chem 2000; 275 (21): 16023-16029.
59. Hayashi A, Suzuki H, Itoh K, Yamamoto M, Sugiyama Y. Transcription factor Nrf2 is required for the constitutive and inducible expression of multidrug resistance-associated protein 1 in mouse embryo fibroblasts. Biochem Biophys Res Commun 2003; 310: 824-829.
60. Hayes JD, McMahon M. Molecular basis for the contribution of the antioxidant responsive element to cancer chemoprevention. Cancer Lett 2001; 174: 103-113.
61. Itoh K, Chiba T, Takahashi S etal. An Nrf2/small Maf heterodimer mediates the induction of phase II detoxifying enzyme genes through antioxidant response elements. Biochem Biophys Res Commun 1997; 236: 313-322.
62. Wang GF, Wu SY, Rao JJ etal. Genipin inhibits endothelial exocytosis via nitric oxide in cultured human umbilical vein endothelial cells. Acta Pharmacol Sin 2009; 30: 589-596.
63. Suzuki Y, Kondo K, Ikeda Y, Umemura K. Antithrombotic effect of geniposide and genipin in the mouse thrombosis model. Planta medica 2001; 67: 807-810.
64. Yamazaki M, Chiba K. Genipin exhibits neurotrophic effects through a common signaling pathway in nitric oxide synthase-expressing cells. Eur J Pharmacol 2008; 581: 255-261.
65. Yamazaki M, Chiba K, Mohri T, Hatanaka H. Activation of the mitogen-activated protein kinase cascade through nitric oxide synthesis as a mechanism of neuritogenic effect of genipin in PC12h cells. Journal of neurochemistry 2001; 79 (1): 45-54.
66. Yamazaki M, Chiba K, Yoshikawa C. Genipin suppresses A23187-induced cytotoxicity in neuro2a cells. Biol Pharm Bull 2009; 32: 1043-1046.
67. Tanaka M, Yamazaki M, Chiba K. Neuroprotective action of genipin on tunicamycin-induced cytotoxicity in neuro2a cells. Biol Pharm Bull 2009; 32: 1220-1223.
68. Lee SO, Jeong YJ, Kim M, Kim CH, Lee IS. Suppression of PMA-induced tumor cell invasion by capillarisin via the inhibition of NF-kappaB-dependent MMP-9 expression. Biochem Biophys Res Commun 2008; 366: 1019-1024.
69. Cao H, Feng Q, Xu W etal. Genipin induced apoptosis associated with activation of the c-Jun NH2-terminal kinase and p53 protein in HeLa cells. Biol Pharm Bull 2010; 33: 1343-1348.
70. Kitano A, Saika S, Yamanaka O etal. Genipin suppresses subconjunctival fibroblast migration, proliferation and myofibroblast transdifferentiation. Ophthalmic Res 2006; 38: 355-360.
71. Kitano A, Saika S, Yamanaka O etal. Genipin suppression of fibrogenic behaviors of the alpha-TN4 lens epithelial cell line. J Cataract Refract Surg 2006; 32: 1727-1735.
72. Zhang CY, Parton LE, Ye CP etal. Genipin inhibits UCP2-mediated proton leak and acutely reverses obesity- and high glucose-induced beta cell dysfunction in isolated pancreatic islets. Cell metabolism 2006; 3: 417-427.
73. Munekage M, Kitagawa H, Ichikawa K etal. Pharmacokinetics of daikenchuto, a traditional Japanese medicine (kampo) after single oral administration to healthy Japanese volunteers. Drug Metabolism and Disposition: the Biological Fate of Chemicals 2011; 39: 1784-1788.
74. Yim JS, Kim YS, Moon SK etal. Metabolic activities of ginsenoside Rb1, baicalin, glycyrrhizin and geniposide to their bioactive compounds by human intestinal microflora. Biol Pharm Bull 2004; 27: 1580-1583.